Koers RavenQuest BioMed Inc. Canadian Securities Exchange
Aandelen
RQB
CA7543871080
Bedrijfsondersteunende diensten
Omzet 2017 | 0,11 0,15 0,1 | Omzet 2018 | 1,26 1,72 1,17 | Marktkapitalisatie | 58,71 mln. 80,25 mln. 54,51 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2017 | -3 mln. -4,1 mln. -2,79 mln. | Nettowinst (verlies) 2018 | -30 mln. -41,01 mln. -27,86 mln. | EV/omzet 2017 * | - |
Nettoliquiditeiten 2017 | 3,15 mln. 4,3 mln. 2,92 mln. | Nettoschuld 2018 | 12,9 mln. 17,63 mln. 11,97 mln. | EV/omzet 2018 | 56.975.119 x |
K/w-verhouding 2017 * |
-
| K/w-verhouding 2018 |
-1,55
x | Werknemers | - |
Dividendrendement 2017 * |
-
| Dividendrendement 2018 |
-
| Vrij verhandelbaar | 89,48% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Jay Dhaliwal
CEO | Chief Executive Officer | 35 | 27-11-19 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Jay Dhaliwal
CEO | Chief Executive Officer | 35 | 27-11-19 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+11,36% | 7,78 mld. | |
+14,12% | 2,87 mld. | |
-1,85% | 1,55 mld. | |
-8,42% | 1,1 mld. | |
+23,15% | 851 mln. | |
-5,93% | 734 mln. | |
-3,86% | 604 mln. | |
-21,11% | 525 mln. | |
-14,32% | 509 mln. |